Autor: |
Xue Zhou, Xiaoli Xie, Ting Liu, Shengxiong Chen, Yijun Wang, Jiuna Zhang, Shuling Wang, Yongjuan Wang, Shiying Dou, Ran Qi, Ning Kang, Dongxuan Zhang, Xiaoxu Jin, Ruolin Cui, Huiqing Jiang |
Jazyk: |
angličtina |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Translational Oncology, Vol 15, Iss 1, Pp 101305- (2022) |
Druh dokumentu: |
article |
ISSN: |
1936-5233 |
DOI: |
10.1016/j.tranon.2021.101305 |
Popis: |
Cancer/testis antigens (CTAs) are often aberrantly expressed in cancer stem cells (CSCs) which are responsible for tumor metastasis. Rec8 meiotic recombination protein (REC8), a member of CTAs, shares distinct roles in various cancers, while its contribution to CSCs and colorectal cancer (CRC) remains unclear. We found that overexpression of REC8 facilitated the migration and invasion of CRC cells (DLD-1 and SW480 cells) in vitro and promoted the liver metastasis of CRC in vivo. Moreover, REC8 is highly expressed in CRC stem-like cells and is required for the maintenance of CSC stemness. Mechanistic studies suggested that REC8 mediated through the activation of Bruton tyrosine kinase (BTK). Inhibition of BTK by ibrutinib not only suppressed the migration and invasion-promoting ability, but also declined the increased expression of p-BTK, p-Akt, β-catenin, and CSC markers upon REC8 overexpression. Importantly, high expression of REC8 in cancerous tissues was related to advanced clinical stage and lymph node metastasis of 62 CRC patients, and REC8 was enriched in the cancerous cells positive for CSC markers. Collectively, our results indicate that REC8 promotes CRC metastasis by increasing cell stemness through BTK/Akt/β-catenin pathway. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|